MAOA and prostate carcinoma: ZnPc-MLB demonstrated markedly enhanced uptake in MAO-A-overexpressing prostate cancer cells (DU145 and PC-3), particularly notable at the 8-h incubation point, compared to the reference compound Pc-TEG.